Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 2/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31480509 | 0.83 | CRBN (0.32) | CRBNCYP1A2GAAMAPTRECQL | |
| SCHEMBL31480332 | 0.83 | CRBN (0.32) | CRBNCYP1A2GAAMAPTRECQL | |
| SCHEMBL31480481 | 0.75 | MAPT (0.30) | CRBNMAPT | |
| SCHEMBL31480488 | 0.73 | MAPT (0.31) | MAPT | |
| SCHEMBL31480146 | 0.72 | CRBN (0.34) | PDE2ACRBN | |
| SCHEMBL31480606 | 0.72 | CRBN (0.33) | CRBN | |
| SCHEMBL31480262 | 0.70 | ALDH1A1 (0.38) | MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL31480318 | 0.70 | MAPK1 (0.33) | CRBN | |
| SCHEMBL31480450 | 0.70 | — | — | |
| SCHEMBL16400464 | 0.70 | NPC1 (0.45) | TSHRGAAMAPTNPC1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054361-A1 | COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |